(Q72274191)
Statements
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma (English)
A M Gianni
C Tarella
M Bregni
S Siena
F Lombardi
L Gandola
D Caracciolo
A Stern
G Bonadonna
1 March 1994